Citigroup
FURX

Citigroup’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Citigroup’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-360
Closed -$38K – 7613
2014
Q2 		$38K Sell
360
-1,986
-85% -$195K ﹤0.01% 5363
2014
Q1 		$205K Sell
2,346
-574
-20% -$44.3K ﹤0.01% 4307
2013
Q4 		$123K Sell
2,920
-4,303
-60% -$177K ﹤0.01% 5081
2013
Q3 		$318K Buy
7,223
+6,942
+2,470% +$287K ﹤0.01% 3801
2013
Q2 		$9K Buy
+281
New +$9.86K ﹤0.01% 6171

Citigroup's FURX Position: Q3 2014 in Review

Citigroup sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 360 shares — an estimated $38K sold.

Citigroup first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $318K in Q3 2013. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Citigroup reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Citigroup sold 360 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $38K.
  • Citigroup first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Citigroup's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $318K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Citigroup's 13F filing for Q3 2014, filed 14 Nov 2014.